HALOZYME THERAPEUTICS INC - NOTE 0.250% 3/0

Historical Portfolio Holders from Q1 2022 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Debt / NOTE 0.250% 3/0
Principal, excl. options Q2 2024
643M
Holdings value Q2 2024
$613M
Value change Q2 2024
+$7.1M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
56
Number of buys Q2 2024
18
Number of sells Q2 2024
-26
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Principal Value Change Price Investors
2024 Q2 $643M $613M +$7.1M $0.95 56
2024 Q1 $635M $563M -$345K $0.89 59
2023 Q4 $631M $546M +$11.6M $0.86 61
2023 Q3 $615M $522M +$8.76M $0.84 62
2023 Q2 $607M $506M +$19.7M $0.83 64
2023 Q1 $649M $550M +$86.1M $0.85 60
2022 Q4 $443M $429M -$32.5M $0.97 52
2022 Q3 $478M $406M -$209M $0.85 46
2022 Q2 $713M $631M +$142M $0.88 49
2022 Q1 $543M $476M +$476M $0.88 45